Month: September 2011

Mergers & Acquisitions

Direct Energy to Acquire First Choice Power for $270 Million

September 23, 2011 0

Direct Energy to Acquire First Choice Power for $270 Million Continues Growth in North America and Solidifies Texas Business PR Newswire HOUSTON, Sept. 23, 2011 HOUSTON , Sept. 23, 2011 /PRNewswire/ — Direct Energy, North America ‘s largest competitive energy and energy-related services company, has reached an agreement to acquire Texas -based electricity provider First Choice Power, a subsidiary of PNM Resources (NYSE: PNM), for US$270 million in cash plus additional working capital. […]

Momentum Stocks

Corning, Inc. (GLW) – Bear of the Day (GLW)

September 23, 2011 0

Corning, Inc. ( GLW ) is a leading developer of advanced glass substrates for multiple markets. June quarter earnings beat the Zacks Consensus Estimate by a penny, but guidance was soft, reflecting inventory builds at TV manufacturers, which impacted both the Display and Specialty Materials segments […]

Mad Money Episodes

Paid to Wait: CLX

September 22, 2011 0

[cnbc 3000047143] Mad Money’s Cramer says in this rough market, investors need to find companies like Clorox that will pay a healthy dividend. If we really are headed for a recession, this is exactly the kind of stock that can still make investors money in a slowdown. […]

Peter Schiff

Listener Questions 9/22/11 Preview

September 22, 2011 0

[youtube UT44-50e1P8] Aaron from Piedmont, SC: I’m a college student in Greenwood SC. I am worried about my future. Do you think its smart to take out a $2000 student loan and invest it in a precious metal, or is it better not to do anything […]

Mad Money Episodes

Time for Tech Stocks

September 22, 2011 0

[cnbc 3000047213] When bottom fishing for tech stocks, Mad Money’s Jim Cramer says investors should look for beaten down stocks of intact companies, and he thinks EMC Corp. fits the bill. […]

Stock Analysts

Lifeline for Orexigen’s Contrave (ARNA) (OREX) (VVUS)

September 22, 2011 0

Orexigen Therapeutics, Inc. 's ( OREX ) shares climbed significantly following a meeting with the US Food and Drug Administration's (FDA) office of new drugs (OND) regarding the development path for its obesity candidate Contrave. Following the OND’s decision, Orexigen decided to resume the development of Contrave. […]

Stock Analysts

Avis Issues Senior Notes

September 22, 2011 0

Avis Budget Group, Inc. ’s ( CAR ) wholly owned subsidiary, AE Escrow Corporation, in an attempt to finance the purchase of Avis Europe along with meeting its fees and expenses, has recently issued $250.0 million 9.75% notes due 2020. The sale is expected to be completed by October 3, 2011. […]